Tin tức Y tế
T2D who have cardiovascular disease, CKD, or both, the oral formulation of semaglutide GLP-1 recept...
The ACP developed this guideline based on the best available evidence on the benefits, harms, patien...
Updates on chronic kidney disease (CKD) diagnosis, use of sodium–glucose cotransporter-2 (SGLT-2) in...
Researchers postulated that brain insulin responsiveness may adapt to dietary changes before weight...
Induction therapy with subcutaneous guselkumab demonstrated significant efficacy in patients with mo...
For adults, WHO recommends less than 2000 mg/day of sodium (equivalent to less than 5 g/day salt), o...
A new dyslipidemia guideline from the American Association of Clinical Endocrinology (AACE)
Romosozumab for 12 months followed by alendronate for 24 months leads to greater improvements in lum...
The US Food and Drug Administration (FDA) has approved suzetrigine 50 mg tablets, a first-in-class n...